BioReference Laboratories Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing. BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season. Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes. How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19? Premium While SARS-CoV-2 test demand will likely remain strong well into 2021, the question of what to do with the built-up capacity in a post-COVID-19 environment looms. Opko Health Q3 Revenues Up 87 Percent The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter. Aug 12, 2020 GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group Mar 14, 2020 Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing Mar 13, 2020 BioReference Partners With NY State to Provide Drive-Through SARS-CoV-2 Testing Mar 5, 2020 Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance Dec 6, 2019 Local Coverage Determinations Roundup: Transplant Genomics, Opko Health Apr 3, 2019 NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education Aug 28, 2018 BioReference Labs' GenPath to Participate in NCI-MATCH Jun 22, 2018 Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework Premium Jan 12, 2018 GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders Nov 22, 2017 Longstanding Genetic Testing Website GeneTests Closing Sep 19, 2017 BioReference, The Garage Form Alliance to Advance Patient Care Jun 7, 2017 UC Health to Have Expanded Access to GeneDx Tests Apr 24, 2017 Diaceutics Inks Deal for BioReference Labs Dx Data Jan 10, 2017 Natera Terminates Bio-Reference Labs NIPT Distribution Agreement Jan 4, 2017 Genetic Testing Firms Establish NIPT Advocacy Organization Jan 4, 2017 Natera Files Suit Against Bio-Reference Laboratories for Breach of Contract Nov 7, 2016 Opko Q3 Revenues Up 108 Percent on Strength of BioReference Sales Oct 11, 2016 Integrating Molecular Tests With EMRs Seen as Essential to Advancing Precision Diagnostics Premium Oct 10, 2016 GeneDx Launches Prenatal Exome Sequencing Test, Plans to Expand Into New Dx Areas Premium May 9, 2016 Opko Q1 Revenues Up Nearly Ninefold Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.